157 related articles for article (PubMed ID: 37974967)
21. New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells.
Yurttaş L; Çiftçi GA
Anticancer Agents Med Chem; 2018; 18(8):1122-1130. PubMed ID: 29521252
[TBL] [Abstract][Full Text] [Related]
22. Multiple kinase pathways involved in the different de novo sensitivity of pancreatic cancer cell lines to 17-AAG.
Liu H; Zhang T; Chen R; McConkey DJ; Ward JF; Curley SA
J Surg Res; 2012 Jul; 176(1):147-53. PubMed ID: 22099584
[TBL] [Abstract][Full Text] [Related]
23. Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: Synthesis of potent bacterial biofilm and MurB inhibitors.
Mekky AEM; Sanad SMH
Bioorg Chem; 2020 Sep; 102():104094. PubMed ID: 32711085
[TBL] [Abstract][Full Text] [Related]
24. A focused library synthesis and cytotoxicity of quinones derived from the natural product bolinaquinone.
Ghods A; Gilbert J; Baker JR; Russell CC; Sakoff JA; McCluskey A
R Soc Open Sci; 2018 Apr; 5(4):171189. PubMed ID: 29765626
[TBL] [Abstract][Full Text] [Related]
25. Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation.
Abe M; Yamashita J; Ogawa M
Cancer; 2000 May; 88(9):2000-9. PubMed ID: 10813710
[TBL] [Abstract][Full Text] [Related]
26. 3-(1,2,3-Triazol-4-yl)-β-Carbolines and 3-(1
Ribeiro JLP; Loureiro JB; Lopes SMM; Saraiva L; Pinho E Melo TMVD
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558961
[TBL] [Abstract][Full Text] [Related]
27. Indole-carbohydrazide linked phenoxy-1,2,3-triazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors: design, synthesis, in vitro α-glucosidase inhibition, and computational studies.
Emadi M; Mosavizadeh-Marvest F; Asadipour A; Pourshojaei Y; Hosseini S; Mojtabavi S; Faramarzi MA; Larijani B; Mohammadi-Khanaposhtani M; Mahdavi M
BMC Chem; 2023 Jun; 17(1):56. PubMed ID: 37316931
[TBL] [Abstract][Full Text] [Related]
28. Comparative study between the anti-P. falciparum activity of triazolopyrimidine, pyrazolopyrimidine and quinoline derivatives and the identification of new PfDHODH inhibitors.
Silveira FF; de Souza JO; Hoelz LVB; Campos VR; Jabor VAP; Aguiar ACC; Nonato MC; Albuquerque MG; Guido RVC; Boechat N; Pinheiro LCS
Eur J Med Chem; 2021 Jan; 209():112941. PubMed ID: 33158577
[TBL] [Abstract][Full Text] [Related]
29. The marine natural product microsclerodermin A is a novel inhibitor of the nuclear factor kappa B and induces apoptosis in pancreatic cancer cells.
Guzmán EA; Maers K; Roberts J; Kemami-Wangun HV; Harmody D; Wright AE
Invest New Drugs; 2015 Feb; 33(1):86-94. PubMed ID: 25416019
[TBL] [Abstract][Full Text] [Related]
30. Novel 1,2,3-Triazole-Containing Quinoline-Benzimidazole Hybrids: Synthesis, Antiproliferative Activity, In Silico ADME Predictions, and Docking.
Krstulović L; Mišković Špoljarić K; Rastija V; Filipović N; Bajić M; Glavaš-Obrovac L
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836794
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and anti-cancer screening of novel heterocyclic-(2
Penthala NR; Madhukuri L; Thakkar S; Madadi NR; Lamture G; Eoff RL; Crooks PA
Medchemcomm; 2015 Aug; 6(8):1535-1543. PubMed ID: 27066215
[No Abstract] [Full Text] [Related]
32. 6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agents.
Gangjee A; Zhu Y; Queener SF
J Med Chem; 1998 Nov; 41(23):4533-41. PubMed ID: 9804692
[TBL] [Abstract][Full Text] [Related]
33. Relative Biological Effectiveness (RBE) of [
Boyle AJ; Cai Z; O'Brien S; Crick J; Angers S; Reilly RM
Nucl Med Biol; 2023; 122-123():108367. PubMed ID: 37506639
[TBL] [Abstract][Full Text] [Related]
34. DFT and CV data of 4-phenyl-substituted dichloro(bis{2-[1-(phenyl)-1H-1,2,3-triazol-4-yl-κN
Conradie J; Conradie MM; Mtshali Z; Potgieter JH
Data Brief; 2018 Dec; 21():1458-1471. PubMed ID: 30456271
[TBL] [Abstract][Full Text] [Related]
35. [Phospholipase C δ1 (PLCD1) inhibits the proliferation, invasion and migration of CAPAN-1 and BXPC-3 pancreatic cancer cells].
Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):739-45. PubMed ID: 27371838
[TBL] [Abstract][Full Text] [Related]
36. Quinolone-1-(2H)-ones as hedgehog signalling pathway inhibitors.
Trinh TN; McLaughlin EA; Abdel-Hamid MK; Gordon CP; Bernstein IR; Pye V; Cossar P; Sakoff JA; McCluskey A
Org Biomol Chem; 2016 Jul; 14(26):6304-15. PubMed ID: 27272335
[TBL] [Abstract][Full Text] [Related]
37. Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
Kuramoto M; Yamashita J; Ogawa M
Cancer; 1995 Mar; 75(6):1263-72. PubMed ID: 7882277
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, Hemolytic Studies, and
Shahzadi I; Zahoor AF; Rasul A; Mansha A; Ahmad S; Raza Z
ACS Omega; 2021 May; 6(18):11943-11953. PubMed ID: 34056349
[TBL] [Abstract][Full Text] [Related]
39. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Tong WG; Ding XZ; Hennig R; Witt RC; Standop J; Pour PM; Adrian TE
Clin Cancer Res; 2002 Oct; 8(10):3232-42. PubMed ID: 12374694
[TBL] [Abstract][Full Text] [Related]
40. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
